1 completed, 1 unknown. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
| Phase 2 | 1 | Completed 1 |
Follow Lipoatrophy: new trials by email Literature Review of Lipoatrophy trials Research Report on Lipoatrophy
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH. Berberine, Placebo - Metabolic Syndrome, HIV-1-infection | Phase 3 | Unknown | Hospital Civil de Guadalajara | 40 | 2021-04-01 | 2021-04-26 |
| Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy NucleomaxX, NucleomaxX placebo - HIV Infections, Lipoatrophy | Phase 2 / Phase 3 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 167 | 2006-09-01 | 2021-11-04 |
Lipodystrophy (2) · Dyslipidemias (1) · Glucose Intolerance (1) · HIV Infections (1) · Metabolic Syndrome (1)
Lipid Metabolism Disorders (2) · Metabolic Diseases (2) · Nutritional and Metabolic Diseases (2) · Skin Diseases (2) · Skin Diseases, Metabolic (2) · Skin and Connective Tissue Diseases (2) · Blood-Borne Infections (1) · Communicable Diseases (1) · Genital Diseases (1) · Glucose Metabolism Disorders (1) · Hyperglycemia (1) · Hyperinsulinism (1) · Immune System Diseases (1) · Immunologic Deficiency Syndromes (1) · Infections (1)
Berberine (1)
Hospital Civil de Guadalajara (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Puerto Rico (1) · United States (1)
Grace A. McComsey, MD (1) · Judith A. Aberg, MD (1)